| 英文别名： |
2-Chloro-9H-thioxanthen-9-one;2-Chlorothoxanthone;Zuclopenthixol;2-chloro-9h-thioxanthen-9-on;KayacureCTX;NissoCureCTX;QuantacureCTX;Sandoray1050;Thioxanthen-9-one,2-chloro-;UCI100;Photoinitiator-CTX;2-CHLOROTHIAXANTHONE;2-Chlorothioxanthen-9-one;2-CHLOROTHIOXANTHENE-9-ONE;2-Chlorothioxanthone;9H-Thioxanthen-9-one, 2-chloro-;MLS000584923;RGS87T004B;SMR000207308;Sandoray 1050;2-chloro-thioxanthone;PubChem10692;2-chloro-9-thioxanthone;C13H7ClOS;2-chloro-9-thioxanthenone;2-chloro-thioxanthen-9-one;2-chloranylthioxanthen-9-one;KSC448A6T;Thioxanthen-9-one, 2-chl;F13426;SCHEMBL37075;W-104069;2-Chlorothiaxanthone;UNII-RGS87T004B;CHLORPROTHIXENE HYDROCHLORIDE IMPURITY E [EP IMPURITY];Q27288110;Chlorprothixene Hydrochloride Imp. E (EP); Chlorprothixene Imp. E (EP); 2-Chloro-9H-thioxanthen-9-one; Chlorprothixene Hydrochloride Impurity E; Zuclopenthixol Decanoate Impurity B; Chlorprothixene Impurity E;tert-ButylS-(4,6-dimethylpyrimidin-2-yl)thiolcarbonate;Thioxanthen-9-one, 2-chloro-;cid_618848;2-chlorthioxanthen-9-on;C13H9ClOS;CS-W020969;BDBM74837;EU-0066618;EINECS 201-667-2;MFCD00005067;CHEMBL1404465;HMS2577I05;InChI=1/C13H7ClOS/c14-8-5-6-12-10(7-8)13(15)9-3-1-2-4-11(9)16-12/h1-7;2-Chlorothioxanthen-9-one, 98%;Zuclopenthixol impurity B, European Pharmacopoeia (EP) Reference Standard;SY033135;DTXSID90861667;AKOS000507449;86-39-5;AS-12064;2-chlorothioxanthene-9-one;2-Chloro-9H-thioxanthen-9-one #;AC-8084;FT-0612028;SR-01000597219;SR-01000597219-1;AI3-28100;2-Chloro-9H-thioxanthen-9-one (ACI);Thioxanthen-9-one, 2-chloro- (6CI, 7CI, 8CI);CTX;Gencure CTX;Kayacure CTX;Kayacure DETA-S;Nisso Cure CTX;Omnirad CTX;Quantacure CTX;Speedcure CTX;UCI 100;2-Chlorothioxanthone,98% |
沪公网安备31011402010658号 
